KCNK16 and diabetes mellitus: Together these data highlight the crucial role of TALK-1 in β-cell function and glucose homeostasis and raises the possibility of TALK-1 inhibition as a druggable target for not only KCNK16-associated MODY but possibly for other forms of diabetes.